found that curcumin significantly improved the growth‐inhibitory effect of daunorubicin in primary CD34+/CD38− AML cells, largely through the downregulation of osteopontin (OPN), a gene associated with leukemic stem cell survival and chemoresistance via the AKT/mTOR pathway (Ahmed et al. 2020). Here, MTOR is linked to acute myeloid leukemia.